🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Ye Yang

Nanjing University of Chinese Medicine

ORCID: 0000-0003-0228-5102

Also affiliated with Yangtze University, Chinese Academy of Medical Sciences & Peking Union Medical College, National Cancer Center, Jiangsu Vocational College of Medicine

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 7 papers. Top paper: “Cryptic splice mutation in the fumarate hydratase gene in patients with clinical manifestations of Hereditary Leiomyomatosis and Renal Cell Cancer”.

Cryptic splice mutation in the fumarate hydratase gene in patients with clinical manifestations of Hereditary Leiomyomatosis and Renal Cell Cancer

Human Molecular Genetics(2023)10.1093/hmg/ddad131
N/A
0.292DataRank · unranked
6 citations

Geetha Mariah Cawthon, Christina M. Fitzsimmons, Minervo Perez, Christopher J. Ricketts, Cathy D. Vocke +11 more

DEAF1 confers resistance to adriamycin-induced apoptosis and pyroptosis in multiple myeloma

Drug Resistance Updates(2026)10.1016/j.drup.2025.101344
N/A
0.104DataRank · unranked
1 citations

Yongxin Wei, Shuang Liu, Lu Chen, Xuhui Wang, Zihao Liu +8 more

Polyoxypregnanes as safe, potent, and specific ABCB1-inhibitory pro-drugs to overcome multidrug resistance in cancer chemotherapy in vitro and in vivo

Acta Pharmaceutica Sinica B(2021)10.1016/j.apsb.2020.12.021
N/A
0DataRank · unranked
25 citations

Chun Yin, Jiang Ma, Stella Chai, Chunyuan Zhang, Sheng Yao +6 more

Targeting Metabolic Vulnerability by Combining NAMPT Inhibitors and Disulfiram for Treatment of Recurrent Ovarian Cancer

Research Square(2024)10.21203/rs.3.rs-4150814/v1
N/A
0DataRank · unranked
0 citations

Kei Kudo, Daniel R. Crooks, Yoshimi Endo Greer, Ye Yang, Jeffrey Brender +10 more

Targeting metabolic vulnerability by combining NAMPT inhibitors and disulfiram for treatment of recurrent ovarian cancer

Cell Death and Disease(2025)10.1038/s41419-025-07672-3
N/A
0DataRank · unranked
4 citations

Yoshimi Endo Greer, Daniel R. Crooks, Ye Yang, Jeffrey Brender, Teruhiko Yoshida +10 more

Metabolic and imaging phenotypes associated with RB1 and TP53 loss in prostate cancer

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.11.15.567250
N/A
0DataRank · unranked
0 citations

Margaret White, Kazutoshi Yamamoto, Daniel R. Crooks, Supreet Agarwal, Ye Yang +12 more

Targeting mutant p53-R248W reactivates WT p53 function and alters the onco-metabolic profile

Frontiers in Oncology(2023)10.3389/fonc.2022.1094210
N/A
0DataRank · unranked
5 citations

Lisa M. Jenkins, Daniel R. Crooks, Deborah R. Surman, Sharlyn J. Mazur, Yuan Xu +9 more